Trulieve Cannabis Corp.
TRLV
$12.11
$0.121.00%
NYSE
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -5.51% | -2.17% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.51% | -2.17% | |||
| Cost of Revenue | -6.87% | -1.12% | |||
| Gross Profit | -4.58% | -2.87% | |||
| SG&A Expenses | -2.98% | -16.95% | |||
| Depreciation & Amortization | -13.52% | 1.17% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.03% | -8.18% | |||
| Operating Income | -1.82% | 82.70% | |||
| Income Before Tax | -1,620.21% | 769.66% | |||
| Income Tax Expenses | 0.49% | -54.37% | |||
| Earnings from Continuing Operations | -12,160.79% | 107.47% | |||
| Earnings from Discontinued Operations | 35.16% | -177.00% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -29.27% | -82.43% | |||
| Net Income | -16,973.44% | 105.61% | |||
| EBIT | -1.82% | 82.70% | |||
| EBITDA | -6.60% | 25.67% | |||
| EPS Basic | -16,952.80% | 105.59% | |||
| Normalized Basic EPS | -1,615.32% | 155.00% | |||
| EPS Diluted | -16,952.80% | 105.59% | |||
| Normalized Diluted EPS | -1,615.32% | 155.00% | |||
| Average Basic Shares Outstanding | 0.09% | 0.44% | |||
| Average Diluted Shares Outstanding | 0.09% | 0.44% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||